Sarcopenia affected 59% of children with Crohn's disease (CD) at the diagnosis and increased their risk for clinical relapses within the first year. Researchers conducted a retrospective study at the ...
Upadacitinib induced clinical response in 75% and clinical remission in 56% of children with refractory Crohn's disease by week 8. The study involved 100 children, with most receiving a 45 mg daily ...
Integrating Brain-Gut Behavior Therapy in Crohn’s Care Drs Ryan Ungaro and Laurie Keefer discuss brain-gut behavior therapy and the potential for combining it with biologic treatment in Crohn’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback